We report the case of a woman in her early 40s presenting with a large, cutaneous-involved, hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative, right breast cancer with neuroendocrine differentiation. Here, NR4A1 is linked to breast cancer.